Gangloff Scott A.

Chief Technology Officer at AKRO; SVP, Development & Mfrg at OTLK

Sold, on record
$187k
Dollars the filings state
Form 4 sales
2
Latest Jun 18, 2025
Form 144 notices
0
Proposed sales
Companies
2
Filed as an executive or holder

Companies

  • AKROAkero Therapeutics, Inc.Chief Technology Officer
  • OTLKOutlook Therapeutics, Inc.SVP, Development & Mfrg

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale OTLKUnusual
    Nov 11 2016

    Sold 37,369 shares at $3.75 ($140k)

    Gangloff Scott A., SVP, Development & Mfrg

    Sold 32.2% of holdings ($435k position)78,573 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale AKRONo plan
    Jun 18 +3141 days

    Sold 848 shares at $54.84 ($47k)

    Gangloff Scott A., Chief Technology Officer

    No 10b5-1 planSold 3.5% of holdings ($1.3M position)23,452 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (2)

Form 144 notices and Form 4 sales by Gangloff Scott A.
Source
Jun 18, 2025AKROChief Technology OfficerForm 4 sale848$47k3.5%No planSEC
Nov 11, 2016OTLKSVP, Development & MfrgForm 4 sale37,369$140k32.2%UnusualSEC